CordenPharma Receives Supplier Recognition Award From Esperion
By: Colorado BioScience Association Date: 04/15/2022
CordenPharma is honored to announce the receipt of a Supplier Recognition Award from Esperion Therapeutics that was presented by Esperion’s Sr. Vice President of Manufacturing Planning &...
Learn MoreAllosource Recognized as the Top Colorado Bioscience Manufacturer
By: Colorado BioScience Association Date: 04/15/2022
AlloSource®, one of the largest allograft providers in the U.S., creating innovative cellular and tissue products to help surgeons heal their patients, has been recognized as 2022 Bioscience Manufactu...
Learn MoreEdgewise-Funded Natural History Trial Of Becker Muscular Dystrophy (BMD) Now Enrolling
By: Colorado BioScience Association Date: 04/15/2022
Edgewise Therapeutics, Inc. (NASDAQ: EWTX), a clinical-stage biopharmaceutical company focused on developing orally bioavailable, small molecule therapies for the treatment of rare muscle disorders, t...
Learn MoreCEO Antoinette Gawin will serve as Group Managing Executive Officer in Terumo Corporation’s New Executive Officers’ Management System
By: Colorado BioScience Association Date: 04/14/2022
Terumo Blood and Cell Technologies, a medical technology company, announces the appointment of Antoinette Gawin to serve as Group Managing Executive Officer (GMEO) for Terumo Corporation (TSE:4543)....
Learn MoreTerumo Blood and Cell Technologies Appoints Gene Stellon to Lead Innovation and Development
By: Colorado BioScience Association Date: 04/06/2022
Terumo Blood and Cell Technologies, a medical technology company, recently appointed Gene Stellon as Senior Vice President, Innovation and Development (I&D). He will serve on the Executive Managem...
Learn MoreGilead Jumps Out Ahead of BMS in Second-Line B-Cell Lymphoma
By: Colorado BioScience Association Date: 04/06/2022
Kite Pharma, a subsidiary of Gilead, announced that Yescarta (axicabtagene ciloleucel), a chimeric antigen receptor (CAR) T-cell therapy, has been approved by the U.S. Food and Dru...
Learn MoreWeekly Policy Update: State Regulation of PFAS
By: Colorado BioScience Association Date: 03/18/2022
The regulatory environment regarding the usage of perfluoroalkyl and polyfluoroalkyl chemicals (PFAS) in medical devices and other products is evolving to include potential action on the state level....
Learn MoreGelSana Therapeutics Wins UNC Entrepreneurial Challenge
By: Colorado BioScience Association Date: 03/17/2022
The University of Northern Colorado's Monfort College of Business has announced the winners of the 2022 Entrepreneurial Challenge. After making improvements to their business plans based on judges’ fe...
Learn MoreEnveda Biosciences Adds Drug Development Leaders to Scale Efforts and Accelerate Progress
By: Colorado BioScience Association Date: 03/17/2022
Enveda Biosciences, a leading biotechnology company harnessing nature’s chemistry to develop next-generation small molecule therapies, today announced the addition of three leaders to further scale an...
Learn MoreColorado's Women-founded Startups Make Huge Strides
By: Colorado BioScience Association Date: 03/17/2022
CBSA member Inscipta is mentioned in Colorado's startups success. In a record year for venture capital in Colorado, firms founded by women saw sizable gains, too. Why it matters: The VC...
Learn More